JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakashima, N
Right arrow Articles by Nakanishi, Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakashima, N
Right arrow Articles by Nakanishi, Y
Journal of Clinical Pathology 2005;58:583-589
© 2005 BMJ Publishing Group Ltd & Association of Clinical Pathologists


ORIGINAL ARTICLE

The p53–Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia

N Nakashima, K Kuwano, T Maeyama, N Hagimoto, M Yoshimi, N Hamada, M Yamada, Y Nakanishi

Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3–1–1, Maidashi, Higashi-ku, Fukuoka 812–8582, Japan

Correspondence to:
Dr K Kuwano
Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3–1–1, Maidashi, Higashi-ku, Fukuoka 812–8582, Japan; kkuwano{at}kokyu.med.kyushu-u.ac.jp Background: Wild-type p53 is increased during cellular responses to various stresses. Mdm2, which is induced by p53, regulates p53 protein concentrations through the ubiquitin–proteasome pathway.

Aim: To investigate whether the Mdm2 mediated ubiquitination of p53 is associated with epithelial cell apoptosis in idiopathic pulmonary fibrosis (IPF).

Methods: Immunohistochemistry and western blot analysis were carried out on lung samples obtained by lung biopsy from patients with IPF and non-specific interstitial pneumonia (NSIP).

Results: The expression of p53, phosphorylated p53, Mdm2, p21, and Bax was upregulated in epithelial cells from patients with IPF and NSIP compared with normal lung parenchyma. Except for p21, there was a significant increase in the expression of these factors in IPF compared with NSIP. In addition, the number of apoptotic cells and the number of p53 and Bax positive cells was increased compared with controls. p53 conjugated with Mdm2 was decreased in IPF compared with NSIP and controls. Ubiquitinated p53 was increased in both IPF and NSIP compared with controls.

Conclusions: Signalling molecules associated with p53 mediated apoptosis may participate in epithelial cell apoptosis, and the attenuation of p53–Mdm2 conjugation and of p53 degradation may be involved in the epithelial cell apoptosis seen in IPF. Augmented epithelial apoptosis in IPF may lead to the poor prognosis compared with NSIP.


Abbreviations: IPF, idiopathic pulmonary fibrosis; JNK, c-jun N-terminal kinase; NSIP, non-specific interstitial pneumonia; TUNEL, terminal deoxynucleotidyl transferase mediated dUTP nick end labelling

Keywords: Mdm2; p53; ubiquitination; apoptosis; idiopathic pulmonary fibrosis




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Yamasaki, H.-R. Kang, R. J. Homer, S. P. Chapoval, S. J. Cho, B. J. Lee, J. A. Elias, and C. G. Lee
P21 Regulates TGF-{beta}1-Induced Pulmonary Responses via a TNF-{alpha}-Signaling Pathway
Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 346 - 353.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
V. J. Thannickal and J. C. Horowitz
Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.
Proceedings of the ATS, January 1, 2006; 3(4): 350 - 356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.